Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Thomas Jefferson University
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
OHSU Knight Cancer Institute
Thomas Jefferson University
City of Hope Medical Center
City of Hope Medical Center
Northwestern University
City of Hope Medical Center
Mayo Clinic
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
OHSU Knight Cancer Institute
Virginia Commonwealth University